This inventor holds 7 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: Medincell S.a., Medincell, Other. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
5 out of 11 
2 out of 4 
2 out of 834,659 Years Active: 2023-2025
Title: The Innovations of Christophe Roberge
Introduction
Christophe Roberge is an innovative inventor based in Jacou, France, recognized for his contributions to the field of drug delivery systems. With a total of four patents to his name, Roberge has made significant strides in developing formulations that aid in the treatment of psychiatric diseases. His research and inventions demonstrate a profound understanding of complex biopolymer systems and their applications in medicine.
Latest Patents
Roberge's latest patents include two noteworthy inventions. The first is a drug delivery formulation designed for treating psychiatric diseases and disorders, which comprises an injectable formulation containing risperidone and specific copolymers at a concentration of 250-400 mg/mL with an injection volume of 1 mL or less. The second patent focuses on a biodegradable block copolymer drug delivery composition. This innovative composition includes a mixture of at least three different block copolymers, combining both triblock and diblock configurations to enhance drug delivery efficiency, along with a pharmaceutically active ingredient.
Career Highlights
Over the years, Christophe Roberge has worked at Medincell, a company renowned for its innovative approaches in the field of drug delivery. His work has contributed to advancing therapeutic technologies that have the potential to impact patient care positively.
Collaborations
Throughout his career, Roberge has collaborated with esteemed colleagues such as Anthony Rech and Jean-Manuel Cros. These collaborations have fostered an environment of knowledge exchange and innovation, enhancing the development of his pioneering inventions.
Conclusion
Christophe Roberge represents the forefront of innovation in drug delivery systems. With his expertise and recent patents, he continues to pave the way for advancements in treating psychiatric disorders and improving patient outcomes. His work not only highlights the importance of collaboration in scientific research but also exemplifies how innovative thinking can lead to practical solutions in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile